Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The Evolving Relationship of LIMS and Mobile Devices

Published: Wednesday, May 22, 2013
Last Updated: Wednesday, May 22, 2013
Bookmark and Share
An Interview with Abbott's Clive Baron about the new STARLIMS Version 11 and how it will leverage mobile devices.

Since the 2010 acquisition of STARLIMS by Abbott, the LIMS division has grown to 400+ employees while STARLIMS is now installed in some 800+ laboratories in 40 countries worldwide.  

At the recent Pittsburgh Conference (Pittcon) in Philadelphia, PA in March, 2013, the upcoming release was announced of a new STARLIMS Version 11 to be available in June.  The new version will expand STARLIMS user functionality to include mobile device applications, advanced analytics and HTML5 compatibility.  According to the company, these features will allow STARLIMS users to work on the "right screen for the task" with an expanded platform to access LIMS information anywhere.  Technology Networks' Informatics Editor Helen Gillespie sat down with Clive Baron, General Manager for STARLIMS Global Commercial Operations, for more insights into the new version and its capabilities.

Gillespie: How does STARLIMS leverage the cloud?

Baron:  We've been partnering for the past two years with one of the leading cloud platform vendors and are now ready to go to market after beta testing the new version with a number of customers.  Version 11 will leverage an enabling technology that allows the lab and its users to focus on mission-critical business needs, such as their research, not trying to perform routine sample management tasks.  STARLIMS Version 11 takes advantage of cloud technology to offer access anywhere using any device, but the core system is on a secure server behind the customer's firewall.

Gillespie: How do the mobile device attributes of STARLIMS 11 work?

Baron:  The world has gone mobile.  According to research by checkpoint.com, 89% of mobile devices [in a business environment? need the link to the study] connect to a corporate network.  But people use different mobile devices for different tasks.  Our approach with STARLIMS 11 was to re-define the LIMS user experience with features that enables users to use the right screen for the right task.  For example, a lab manager can check the lab KPIs or release urgent samples while out of the lab.  Or, a lab client can request analysis, view sample status, and download reports using the browser-diagnostic HTML5 module.  It doesn't matter what they use to do this, the system automatically delivers the right screen for the particular mobile device.

Gillespie:  Tell me more about Abbott's approach to mobility; how did you come up with the new capabilities in STARLIMS Version 11?

Baron:  We spent a lot of time analyzing the way mobile devices are used and we found that people use devices for specific tasks, so there was no need to replicate the entire STARLIMS functionality for say a smartphone.  

Instead, the main STARLIMS 11 system is still desktop-based, while HTML5 compatibility enables the use of native mobile applications that allow users to perform specific tasks on mobile devices using HTML5-based forms.  Existing XFD forms running on Internet Explorer will continue to be the primary platform.  The key was to streamline the workflows to use mobile technology in the way that made most sense for the lab.  HTML5 enables STARLIMS 11 user to take advantage of the camera, GPS, barcode scanning and other features that mobile devices offer. 

Mobility isn't about taking your desktop screen and putting it on your tablet.  These tools are very different.  What we've done is taken the basic product and extended it into the mobile arena with interfaces for the appropriate tool.  

For instance, we partnered with Microsoft to create built-in Windows screens for evidence collection at a crime site using the camera and GPS features of a tablet.  In another case, we used a JAD decision designer tool to configure a template that enables the user to review KPIs, perform results approval and sample log-in on a mobile device.  The design is scalable.  Once published, the system automatically indicates to the device which OS and screen to use.  The tablet screen is different from a smartphone screen.  For example, results release is a smartphone app because not a lot of data needs to be viewed.  

Gillespie:  What are STARLIMS new advanced analytics functions?

Baron:  We pushed advanced analytics into the mobile sphere. STARLIMS 11 has advanced analytics capabilities with out-of the-box dashboards that can make an immediate impact on laboratory operations, such as optimizing workflow and identifying bottlenecks.  Viewing data from powerful visualizations provides insights and trends to help make better decisions. Again, lab personnel can access a dashboard from anywhere, from their mobile device.

Because the advanced analytics delivers fast answers to ‘what if?’ questions, this means that lab planning considerations can be rapidly turned into actionable solutions.  A lab considering a new test for its clinical menu, for example, would want to analyze potential revenue and profitability. With advanced analytics, financial projections, profit and loss estimates and workflow and productivity data can be accessed on the spot for prompt analysis and decision-making.

All these applications and functions will be offered out of the box with STARLIMS Version 11 and enable users to start up quickly.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Wednesday, September 28, 2016
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Friday, September 23, 2016
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Wednesday, September 21, 2016
AACC 2016 Marketplace Report
Novel immunoassays, analyzers, and molecular diagnostics test the waters at AACC 2016.
Friday, August 19, 2016
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Tuesday, August 02, 2016
Computational Method Offers Significant Boost in Finding New Cancer Targets
MIT and ARIAD Pharmaceuticals team have identified evidence of significant cancer mutations.
Wednesday, July 13, 2016
Investigating Splicing Efficiency in HRAS to Control Costello Syndrome Phenotype and Frequency in Cancer
A team of researchers from universities in Denmark and the USA have investigated a patient with an attenuated phenotype of Costello syndrome.
Wednesday, July 06, 2016
Open Source Seed Initiative – A Welcome Boost to Global Crop Breeding
A team of plant breeders, farmers, non-profit agencies, seed advocates, and policymakers have created the Open Source Seed Initiative.
Wednesday, June 29, 2016
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Tuesday, June 28, 2016
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Wednesday, June 22, 2016
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Friday, June 17, 2016
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Wednesday, June 15, 2016
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Friday, May 13, 2016
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Friday, May 06, 2016
Pittcon 2016: Accelerating Innovation And Enhancing Productivity With Technology
Collaboration and externalization of data highlight evolving lab operations.
Wednesday, March 30, 2016
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!